Collectively, these results suggest that ACC1 is involved in regulating intracellular FAO and ROS levels, thereby promoting the survival of NSCLC cells during gefitinib treatment (Fig. 7I). The gene discussed is ACACA; the disease is non-small cell lung carcinoma.